Triaminic and Theraflu Thin Strips Receive 'Best Product of 2004 Award'
At First Convenience Industry News 'Stars of the Industry' Awards Ceremony
PARSIPPANY, N.J., Nov. 1 /PRNewswire-FirstCall/ -- A mere three weeks after their official launch, Triaminic(R) and Theraflu(R) Thin Strips(TM) have been named "Best Product of 2004" by Convenience Industry News (CIN) magazine. Thin Strips(TM), the first multi-symptom cough and cold medicines to deliver an accurate dose in a thin film form, were selected from more than 100 applicants for their portability, convenience, and consumer acceptance. The CIN judging panel, comprised of convenience-store industry professionals, based its selection on the five factors of taste and quality ingredients, packaging, consumer acceptance, innovation, differentiation, and convenience. The winners were named at the recent National Association of Convenience Stores Show in Las Vegas, Nevada. Convenience Industry News' marketing director, Leila Khalil, commented, "The competition for the first CIN Awards was incredibly strong and the category of general merchandise 'Best Product of 2004' was one of the toughest to judge. The diversity of products entered in this category, such as batteries, cameras, mints, and air fresheners, meant that the judges had to hone in on each product's unique attributes and compare them on their benefits to consumers. Novartis' Thin Strips products impressed the judges with their innovation. We believe the combination of thin film technology with active medicine is certain to gain wide consumer acceptance and pave the way for other medicines to move to this portable, exceptionally convenient form. In turn, we expect that Thin Strips will help deliver excellent growth for the convenience store category." Growth in the over-the-counter cough/cold treatment category is traditionally driven by new product innovation, with a 17.6 percent growth in dollar sales in the 2002-2003 and 2003-2004 cough/cold seasons attributable to new product launches(1). "Product innovation, such as Thin Strips, is critical to the category and fuels growth by continuing to improve consumer compliance and bringing new consumers to the category," continued Khalil. The convenience store category is of significant importance to manufacturers, with more than 100,000 stores across the US achieving gross sales of $290.6 billion in 2002(2). "Novartis Consumer Health, Inc. is delighted to be recognized and honored by Convenience Industry News. With 40 years of "firsts" including hot liquids, chewable tablets, vapor patches and now Thin Strips, the company has made a firm commitment to delivering innovative self-medication treatments that address consumers' demands for convenience. This commitment to product development helps drive category growth while giving our retail partners the products they need, when they need them," said Jeff Vernimb, vice president, Marketing, Novartis Consumer Health, OTC. Theraflu Thin Strips treat the most common symptoms of a cold in children 12 and older and adults and are available in two cherry-flavored treatment options: Long Acting Cough that quiets coughs for up to eight hours, and Multi-Symptom that, as well as quieting coughs, provides temporary relief from a runny nose and sneezing, and soothes itchy, watery eyes and throat. Both cost approximately $5.49 for a 12-strip pack. Triaminic Thin Strips, for children ages 6-12, are available in two treatment options: Long Acting Cough that quiets coughs for up to eight hours, in cherry flavor, and Cough & Runny Nose, in grape flavor. They cost approximately $5.99 for a 16-strip pack. The 'melts on the tongue' portable delivery mechanism is meant to be easy to administer providing fast, accurate dosing that is expected to increase compliance, particularly among children. There is no need for water or measuring, and upon melting, the dose of medicine is swallowed, giving cold sufferers convenient symptom relief while on the road to recovery at home, at work, or on-the-go. About Novartis Consumer Health, Inc. The OTC Business Unit of Novartis Consumer Health, Inc., with headquarters in Parsippany, New Jersey, is a world leader in the development, production and marketing of self-medication products for the in-home treatment and prevention of medical conditions and ailments and for the enhancement of overall health and well being. The OTC Business Unit is part of Novartis AG (NYSE: NVS). About Novartis AG Novartis AG (NYSE: NVS) is a world leader in pharmaceuticals and consumer health. In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in R&D. Headquartered in Basel, Switzerland, Novartis Group companies employ about 78,500 people and operate in over 140 countries around the world. For further information, please consult http://www.novartis.com. About Convenience Industry News Convenience Industry News (CIN) is a comprehensive news source for c-store industry professionals wanting to be informed of the latest trends, innovative marketing ideas, and the top news in every category of the petroleum and convenience store sector. As the retailer's source for new ideas in marketing and merchandising, CIN features product introductions in the core categories of the industry and profiles top executives at the major chains and corporations across the United States. CIN circulation is currently at 42,000 and growing, reaching a high number of independent retailers. CIN communicates not only with all the corporate decision makers, but also with the most difficult group to reach--operators who make the buying decisions at the store level. Convenience Industry News is on track to reach its goal of becoming the reference guide for the convenience store industry. (1) IRI Data -- C/C Season, Oct -- Jan 2002-2004 (2) Convenience Industry News
SOURCE Novartis Consumer Health, Inc.
More by this Source
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.